Changhee Park

7PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 24, 2026
Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab-based chemoimmunotherapy in early triple-negative breast cancer and its clinical significance.

|May 09, 2024
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer.

Hyojin Kim, Seokhwi Kim, Sangjoon Choi

|Mar 30, 2024
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.

Changhee Park, Ho Sup Lee, Ka-Won Kang

|Feb 16, 2024
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study.

Jin-Hee Ahn, Jeeyun Lee, Changhee Park

|Jun 30, 2023
Fertility Preservation in Young Women With Breast Cancer: A Review.

Yeon Hee Hong, Changhee Park, Haerin Paik

|Dec 13, 2019
Clinical Application of Next-Generation Sequencing-Based Panel to BRAF Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies.

Changhee Park, Miso Kim, Min Jung Kim

Pageof 2

Frequent Collaborators

5 joint publications

Tae Min Kim

2 joint publications

Kyung-Hun Lee

1 joint publications

Bhumsuk Keam

1 joint publications

Dong-Wan Kim